Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.

Total
0
Shares
Related Posts